US 12077587
Anti-CD8 antibodies and uses thereof
granted A61KA61K2039/505A61K45/06
Quick answer
US patent 12077587 (Anti-CD8 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K45/06, A61K49/0032, A61K49/0058